Oncimmune "relaunch" already delivering results - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings 00:00:00
Martin brings 30 years corporate finance and business development experience in the CRO, healthcare and pharmaceutical sectors to his role as CEO at Oncimmune. Most recently, Martin was a Global SVP Business Development at Owkin, where he managed all of the commercial teams in the USA and Europe and led new strategic research partnerships.